SLMD benzoyl peroxide spot treatment recalled over benzene contamination
SLMD BP Acne Spot Treatment, 10% benzoyl peroxide, is being recalled because of chemical contamination from the presence of benzene. 2,269 bottles are affected.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 3/5 (High).
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall for chemical contamination of a leave-on skin product, a risk of harm with no injuries reported in the source.
Plain-English summary
SLMD BP Acne Spot Treatment, 10% benzoyl peroxide, in 0.5 fl oz (15 ml) bottles under the Sandra Lee MD brand, is being recalled. The product is distributed by Skin PS Brands of Culver City, California. The action covers 2,269 bottles.
The stated reason is chemical contamination through the presence of benzene. The FDA classified the action as Class II.
Affected lots are 2567200 (expiry 8/1/2026) and 2691600 (expiry 10/30/2027). Distribution was US nationwide.
Consumers who have an affected lot should stop using the product and contact the retailer or the firm about a refund. Anyone with health concerns after using it should speak to a healthcare professional.
The recalled product
- Product
- SLMD BP Acne Spot Treatment, 10% Benzoyl Peroxide, 0.5 fl. oz - 15 mL bottles, Sandra Lee MD, Distributed by Skin PS Brands, Culver City, CA90232.
- Manufacturer
- Owen Biosciences Inc.
- Category
- Drug — Topical acne treatment
- Affected units
- 2,269
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot# 2567200
- Exp.8/1/26 Lot# 2691600
- Exp.10/30/2027
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 4 recalled by Owen Biosciences Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 4 products in this recall →Related recalls
Same manufacturer · Owen Biosciences Inc.
See all →- HighHydroPeptide Clear Alliance benzoyl peroxide serum recalled over benzene contamination
FDA (Drugs) · 2026-04-22
- HighFarmHouse Fresh benzoyl peroxide night lotion recalled over benzene contamination
FDA (Drugs) · 2026-04-22
- HighSLMD benzoyl peroxide acne lotion recalled over benzene contamination
FDA (Drugs) · 2026-04-22
Same hazard · chemical contamination
See all →- ModerateAVID Medical Recalls Plastic Trays Due to Lubricant Contamination
FDA (Devices) · 2026-10-14
- ModerateAVID Medical Recalls Craniotomy Packs Due to Potential Lubricant Contamination
FDA (Devices) · 2026-10-14
- ModerateAvid Medical Recalls 30 DAVINCI LAP/GYN Kits for Lubricant Contamination
FDA (Devices) · 2026-10-14
- SevereFDA Recalls Medical Kits with Contaminated Pericare Wipes
FDA (Devices) · 2026-10-07
- HighFDA Recalls Medical Kits with Contaminated Pericare Wipes
FDA (Devices) · 2026-10-07
Similar recalls
- SevereSkin MD Body Acne Cleanser recalled due to elevated benzene levels
FDA (Drugs) · 2025-10-01
- HighMel Rx acne treatment recalled over elevated benzene in benzoyl peroxide
FDA (Drugs) · 2025-10-01
- HighArtisan of Skin acne treatment recalled over elevated benzene levels
FDA (Drugs) · 2025-10-01
- SevereProactiv Emergency Blemish Relief recalled for benzene contamination
FDA (Drugs) · 2025-04-16
- HighBenzoyl peroxide cleanser recalled after elevated benzene levels were found
FDA (Drugs) · 2025-10-01
- HighWalgreens Acne Control Cleanser recalled for benzene contamination
FDA (Drugs) · 2025-03-19